Prospective Study Evaluating Management of Hypertension Induced by anti-VEGF Therapy in Patients with Active Cancer: VEGFHTN Trial

Authors

• Otoniel Abraham Zelaya, The University of Texas MD Anderson Cancer CenterFollow
• Noah Beinart, The University of Texas MD Anderson Cancer Center
• Adam S. Potter, The University of Texas MD Anderson Cancer Center
• Aung Naing, The University of Texas MD Anderson Cancer Center
• Elizabeth Pierce, The University of Texas MD Anderson Cancer Center
• Rebecca Caldwell, The University of Texas MD Anderson Cancer Center
• Gaspar Pina, The University of Texas MD Anderson Cancer Center
• Praise A. Oderinde, The University of Texas MD Anderson Cancer Center
• Cezar Iliescu MD, The University of Texas MD Anderson Cancer Center
• Efstratios Koutroumpakis, The University of Texas MD Anderson Cancer Center
• Anita Deswal MD MPH, The University of Texas MD Anderson Cancer CenterFollow
• Nicolas Palaskas MD, The University of Texas MD Anderson Cancer Center

Files

Program Affiliation

Partnership for Careers in Cancer Science and Medicine Summer Program

Recommended Citation

Zelaya, Otoniel Abraham; Beinart, Noah; Potter, Adam S.; Naing, Aung; Pierce, Elizabeth; Caldwell, Rebecca; Pina, Gaspar; Oderinde, Praise A.; Iliescu, Cezar MD; Koutroumpakis, Efstratios; Deswal, Anita MD MPH; and Palaskas, Nicolas MD, "Prospective Study Evaluating Management of Hypertension Induced by anti-VEGF Therapy in Patients with Active Cancer: VEGFHTN Trial" (2023). Summer Experience 2023. 25.
https://openworks.mdanderson.org/sumexp23/25

Keywords

Prospective; Anti-VEGF Therapies; Hypertension